您的位置: 首页 > 农业专利 > 详情页

CONCURRENT CHEMOTHERAPY AND IMMUNOTHERAPY
专利权人:
DUKE UNIVERSITY
发明人:
SAMPSON, JOHN H.,BIGNER, DARELL D.,HEIMBERGER, AMY,MITCHELL, DUANE
申请号:
CA2628282
公开号:
CA2628282C
申请日:
2006.11.02
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
The concurrent administration of chemotherapy and immunotherapy has beenconsidered a contraindication because of the concern that the inducedlymphopenia would ablate therapeutic efficacy of immunotherapy. Temozolomidehas been shown to be an effective chemotherapeutic for patients with malignantgliomas and to deprive patients with glioblastoma (GBM) patients of this agentin order to treat with immunotherapy is controversial. Despite conventionaldogma, we demonstrate that both chemotherapy and immunotherapy can bedelivered concurrently without negating the effects of immunotherapy, hi fact,the temozolomide induced lymphopenia may actually be synergistic with apeptide vaccine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充